• Home
  • Team
  • Our Approach
  • Careers
  • News
  • Condensates.com

Press releases and
Dewpoint in the news

  • Dewpoint Therapeutics to put ‘pedal to the metal’ with $77M round

    September 29, 2020

    FierceBiotech

  • Dewpoint Therapeutics Raises $77M Series B Financing to Advance the Development of Drugs That Target Biomolecular Condensates

    September 29, 2020

    Dewpoint

  • 21 biotech startups that are set to take off, according to top VCs

    August 13, 2020

    Business Insider

  • Proteins — and labs — coming together to prevent Rett Syndrome

    July 22, 2020

    Whitehead Institute

  • Dewpoint Therapeutics Collaborates with Merck to Evaluate Novel Approach for the Treatment of HIV

    July 13, 2020

    Dewpoint

  • Discovery of how cancer drugs find their targets could lead to a new toolset for drug development

    June 18, 2020

    Whitehead Institute

  • Dewpoint Therapeutics Appoints Olivier Brandicourt, Jürgen Eckhardt to Board of Directors

    June 17, 2020

    Dewpoint

  • Dewpoint scientific founder Tony Hyman elected to the National Academy of Sciences

    April 28, 2020

    Condensates.com

  • NOMIS Foundation’s Distinguished Scientist and Scholar Award for Tony Hyman

    April 14, 2020

    Max Planck Institute of Molecular Cell Biology and Genetics

  • Dewpoint co-founder Anthony Hyman wins prestigious Wiley Prize

    February 24, 2020

    Dewpoint

Newer 1 2 3 4 5 Older

Dewpoint™

  • Our Company
    • Team
    • Our Approach
    • Careers We’re hiring!
    • News
    • Phase Separation
    • Contact Us
  • Condensates.com
    • Publications
    • Event
    • Jobs
    • Resources
    • About
    • Phase Separation, LLPS
Contact Us

Dewpoint Therapeutics
6 Tide Street, Suite 300
Boston, MA 02210
info@dewpointx.com

© 2019–2021 Dewpoint Therapeutics

  • Privacy
  • Terms